CMND
Income statement / Annual
Last year (2024), Clearmind Medicine Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Clearmind Medicine Inc.'s net income was -$5.25 M.
See Clearmind Medicine Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
10/31/2024 |
10/31/2023 |
10/31/2022 |
10/31/2021 |
10/31/2020 |
10/31/2019 |
10/31/2018 |
10/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$56.34 K
|
$113.38 K
|
$2.57 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$26.70 K
|
-$56.34 K
|
-$113.38 K
|
-$2.57 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.38 M
|
$2.14 M
|
$2.98 M
|
$646.49 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$3.26 M
|
$6.60 M
|
$5.43 M
|
$3.03 M
|
$233.22 K
|
$105.28 K
|
$254.54 K
|
$0.00
|
| Selling & Marketing Expenses |
$1.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.35 M
|
$6.60 M
|
$5.43 M
|
$3.03 M
|
$233.22 K
|
$105.28 K
|
$254.54 K
|
$6.67 K
|
| Other Expenses |
$2.27 M
|
$0.00
|
$113.38 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$8.00 M
|
$8.74 M
|
$8.53 M
|
$3.68 M
|
$233.22 K
|
$105.28 K
|
$254.54 K
|
$6.67 K
|
| Cost And Expenses |
$8.00 M
|
$8.74 M
|
$8.53 M
|
$3.68 M
|
$233.22 K
|
$105.28 K
|
$254.54 K
|
$6.67 K
|
| Interest Income |
$271.22 K
|
$57.97 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$36.16 K
|
$0.00
|
$19.68 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$16.78 K
|
$30.69 K
|
$30.52 K
|
$2.57 K
|
$179.69 K
|
$86.01 K
|
$161.14 K
|
$0.00
|
| EBITDA |
-$7.98 M |
-$8.71 M |
-$8.49 M |
-$3.67 M |
-$233.22 K |
$0.00 |
-$56.27 K |
-$6.67 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.21 M
|
-$3.19 M
|
-$817.80 K
|
-$43.53 K
|
-$179.69 K
|
$0.00
|
$60.00 K
|
$0.00
|
| Income Before Tax |
-$4.88 M
|
-$11.93 M
|
-$9.37 M
|
-$3.72 M
|
-$412.91 K
|
-$105.28 K
|
-$194.54 K
|
-$6.67 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$377.97 K
|
$24.09 K
|
$40.75 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$5.25 M
|
-$11.96 M
|
-$9.41 M
|
-$3.72 M
|
-$412.91 K
|
-$105.28 K
|
-$194.54 K
|
-$6.67 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.69 |
-42.58 |
-168.61 |
-120.3 |
-9.56 |
-6.42 |
-14.018 |
-0.4196 |
| EPS Diluted |
-1.69 |
-42.58 |
-217.2 |
-120.3 |
-9.56 |
-6.42 |
-14.018 |
-0.4196 |
| Weighted Average Shares Out |
$4.27 M
|
$2.02 M
|
$433.34 K
|
$309.11 K
|
$181.30 K
|
$123.33 K
|
$107.79 K
|
$122.22 K
|
| Weighted Average Shares Out Diluted |
$4.27 M
|
$2.02 M
|
$433.34 K
|
$309.11 K
|
$181.30 K
|
$123.33 K
|
$107.79 K
|
$122.22 K
|
| Link |
|
|
|
|
|
|
|
|
